Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model
- PMID: 12761107
- PMCID: PMC155776
- DOI: 10.1128/IAI.71.6.3261-3271.2003
Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model
Abstract
Brucella abortus rough lipopolysaccharide (LPS) mutants were obtained by transposon insertion into two wbk genes (wbkA [putative glycosyltransferase; formerly rfbU] and per [perosamine synthetase]), into manB (pmm [phosphomannomutase; formerly rfbK]), and into an unassigned gene. Consistent with gene-predicted roles, electrophoretic analysis, 2-keto-3-manno-D-octulosonate measurements, and immunoblots with monoclonal antibodies to O-polysaccharide, outer and inner core epitopes showed no O-polysaccharide expression and no LPS core defects in the wbk mutants. The rough LPS of manB mutant lacked the outer core epitope and the gene was designated manB(core) to distinguish it from the wbk manB(O-Ag). The fourth gene (provisionally designated wa**) coded for a putative glycosyltransferase involved in inner core synthesis, but the mutant kept the outer core epitope. Differences in phage and polymyxin sensitivity, exposure or expression of outer membrane protein, core and lipid A epitopes, and lipid A acylation demonstrated that small changes in LPS core caused significant differences in B. abortus outer membrane topology. In mice, the mutants showed different degrees of attenuation and induced antibodies to rough LPS and outer membrane proteins. Core-defective mutants and strain RB51 were ineffective vaccines against B. abortus in mice. The mutants per and wbkA induced protection but less than the standard smooth vaccine S19, and controls suggested that anti O-polysaccharide antibodies accounted largely for the difference. Whereas no core-defective mutant was effective against B. ovis, S19, RB51, and the wbkA and per mutants afforded similar levels of protection. These results suggest that rough Brucella vaccines should carry a complete core for maximal effectiveness.
Figures










Similar articles
-
Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.Vaccine. 2006 Apr 5;24(15):2910-6. doi: 10.1016/j.vaccine.2005.12.038. Epub 2006 Jan 6. Vaccine. 2006. PMID: 16439039
-
Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival.Infect Immun. 1998 Mar;66(3):1008-16. doi: 10.1128/IAI.66.3.1008-1016.1998. Infect Immun. 1998. PMID: 9488389 Free PMC article.
-
Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.Vaccine. 2015 May 21;33(22):2577-83. doi: 10.1016/j.vaccine.2015.04.004. Epub 2015 Apr 11. Vaccine. 2015. PMID: 25869887
-
Rough vaccines in animal brucellosis: structural and genetic basis and present status.Vet Res. 2004 Jan-Feb;35(1):1-38. doi: 10.1051/vetres:2003037. Vet Res. 2004. PMID: 15099501 Review.
-
Lipopolysaccharide as a target for brucellosis vaccine design.Microb Pathog. 2013 May;58:29-34. doi: 10.1016/j.micpath.2012.11.011. Epub 2012 Dec 5. Microb Pathog. 2013. PMID: 23219811 Review.
Cited by
-
Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.Infect Immun. 2004 Jul;72(7):4031-9. doi: 10.1128/IAI.72.7.4031-4039.2004. Infect Immun. 2004. PMID: 15213148 Free PMC article.
-
Genomic Analysis of Natural Rough Brucella melitensis Rev.1 Vaccine Strains: Identification and Characterization of Mutations in Key Genes Associated with Bacterial LPS Biosynthesis and Virulence.Int J Mol Sci. 2020 Dec 8;21(24):9341. doi: 10.3390/ijms21249341. Int J Mol Sci. 2020. PMID: 33302421 Free PMC article.
-
Importance of Lipopolysaccharide and Cyclic β-1,2-Glucans in Brucella-Mammalian Infections.Int J Microbiol. 2010;2010:124509. doi: 10.1155/2010/124509. Epub 2010 Dec 1. Int J Microbiol. 2010. PMID: 21151694 Free PMC article.
-
DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.Vaccine. 2010 Jan 22;28(4):1069-74. doi: 10.1016/j.vaccine.2009.10.113. Epub 2009 Nov 13. Vaccine. 2010. PMID: 19914192 Free PMC article.
-
Intracellular adaptation of Brucella abortus.J Proteome Res. 2009 Mar;8(3):1594-609. doi: 10.1021/pr800978p. J Proteome Res. 2009. PMID: 19216536 Free PMC article.
References
-
- Adams, L. G. 1990. Development of live Brucella vaccines, p. 250-276. In L. G. Adams (ed.), Advances in brucellosis research, Texas A&M University Press, College Station.
-
- Alton, G. G., L. M. Jones, R. D. Angus, and J. M. Verger. 1988. Techniques for the brucellosis laboratory. INRA, Paris, France.
-
- Ariza, J. 1999. Brucellosis: an update. The perspective from the Mediterranean basin. Rev. Med. Microbiol. 10:125-135.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous